Coulter & Justus Financial Services’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,663
Closed -$274K 45
2023
Q3
$274K Sell
19,663
-14
-0.1% -$179 0.2% 33
2023
Q2
$232K Sell
19,677
-4,888
-20% -$55.6K 0.16% 38
2023
Q1
$282K Buy
24,565
+1,234
+5% +$15.3K 0.18% 38
2022
Q4
$290K Buy
23,331
+6,129
+36% +$78.1K 0.2% 40
2022
Q3
$226K Buy
17,202
+490
+3% +$7.24K 0.18% 42
2022
Q2
$233K Buy
+16,712
New +$223K 0.19% 44
2022
Q1
Sell
-11,865
Closed -$161K 46
2021
Q4
$161K Buy
+11,865
New +$168K 0.13% 48

Other funds holding SBRA

Coulter & Justus Financial Services's SBRA Position: Q4 2023 in Review

Coulter & Justus Financial Services sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 19,663 shares — an estimated $274K sold.

Coulter & Justus Financial Services first reported a position in SBRA in Q4 2021 and held it in 7 quarters. The position peaked at $290K in Q4 2022. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • Coulter & Justus Financial Services reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • Coulter & Justus Financial Services sold 19,663 Sabra Healthcare REIT shares in Q4 2023, an estimated $274K.
  • Coulter & Justus Financial Services first reported a position in Sabra Healthcare REIT in Q4 2021 and held it in 7 quarters.
  • Coulter & Justus Financial Services's Sabra Healthcare REIT position peaked at $290K in Q4 2022.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on Coulter & Justus Financial Services's 13F filing for Q4 2023, filed 6 Feb 2024.